On Wednesday August 23, at 09:00 CET, Devyser Diagnostics AB will host an online presentation of its Q2 2023 report (which will have been published earlier on August 23, at 07.30 CET). The presentation will be held in English. 

Dial-in number to the teleconference and a conference ID will be received by registering on the link below:
https://conference.financialhearings.com/teleconference/?id=200933

The presentation will also be webcast and can be accessed from the following web address: 

https://ir.financialhearings.com/devyser-diagnostics-q2-2023

Speakers: CEO Fredrik Alpsten och CFO Sabina Berlin 

The information was submitted for publication, through the agency of the contact persons below, on August 14, 2023, at 11:00 CET.

For more information, please contact:

Fredrik Alpsten, CEO
E-mail: fredrik.alpsten@devyser.com
Tel: +46 706 67 3106

Sabina Berlin, CFO
E-mail: sabina.berlin@devyser.com
Tel: +46 739 519 502

About Devyser

Devyser develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in over 50 countries. Our products are used for advanced genetic testing in the fields of inherited diseases, oncology and transplantation. They provide the opportunity to tailor cancer treatments, diagnose a wide range of genetic diseases and follow up transplant patients. Devyser’s products, and unique, patented solution, which require only a single test tube, simplify genetic testing processes, improve sample throughput, minimize hands-on time and deliver rapid results. Our goal is for every patient to receive a correct diagnosis in the shortest possible time.  

Devyser was founded in 2004 and is based in Stockholm, Sweden. The company has eight in-house sales offices in Europe and the US, as well as a CLIA laboratory in Atlanta, Georgia. In August 2022, Devyser’s quality management system was IVDR-certified. It has been followed by additional IVDR approved products. 

Devyser’s shares are listed on the Nasdaq First North Premier Growth Market Stockholm (ticker: DVYSR). The company’s Certified Adviser is Redeye AB.   

For more information, visit www.devyser.com